Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korea

Clinical trial NCT02010788 · COMPLETED

Trial details

NCT number: NCT02010788
Sponsor: Allergan
Status: COMPLETED
Study type: OBSERVATIONAL

Urinary Incontinence Urinary Bladder, Overactive

Start date: 2014-02-01
Primary completion: 2016-07-01
Enrollment: 523

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.